Attitudes et controverses dans la prevention secondaire de l'accident ischemique cerebral.

Atrial Fibrillation/complications/drug therapy; Carotid Stenosis/complications/therapy; Heart Septal Defects, Atrial/complications/therapy; Humans; Risk Factors; Stroke/etiology/prevention & control

Abstract :

[en] Stroke is the third leading cause of death and the main cause of prolonged disability of adults in industrialised countries. After a first transient ischemic attack or a first minor stroke, the risk of recurrence is 16 folds higher than in control subjects. Therefore each patient suspect of a first ischemic cerebral event should be evaluated for the presence of a specific cause which could be treated. If such a cause is not found, platelet antiaggregant medications should be started.

Disciplines :

Neurology

Author, co-author :

HANS, Grégory ; Centre Hospitalier Universitaire de Liège - CHU > Anesthésie et réanimation

Sadzot, Bernard ; Université de Liège > Département des sciences cliniques > Département des sciences cliniques

Moonen, Gustave ; Université de Liège > Département des sciences cliniques > Département des sciences cliniques

Language :

French

Title :

Attitudes et controverses dans la prevention secondaire de l'accident ischemique cerebral.

Alternative titles :

[en] Controversies in the secondary prevention of stroke

Publication date :

2003

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

287-92

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 May 2015

Statistics

Number of views

38 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Albers GW, Caplan LR, Easton JD, et al. - Transient ischemic attack - proposal for a new definition. N Engl J Med, 2002, 347, 1713-1716.
Johnston SC. - Clinical practice. Transient ischemic attack. N Engl J Med, 2002, 347, 1687-1692.
Messerli FH, Hanley DF Jr., Gorelick PB. - Blood pressure control in stroke patients: what should the consulting neurologist advise? Neurology, 2002, 59, 23-25.
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001, 9287, 1033-1041.
Yusuf S, Sleight P, Pogue J, et al. - Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000, 342, 145-153.
Bosch J, Yusuf S, Pogue J, et al. - Use of ramipril in preventing stroke: double blind randomised trial. BMJ, 2002, 7339, 699-702.
Capes SE, Hunt D, Malmberg K, et al. - Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke, 2001, 32, 2426-2432.
Kagansky N, Levy S, Knobler H. - The role of hyperglycemia in acute stroke. Arch Neurol, 2001, 58, 1209-1212.
Bruno A, Levine SR, Frankel MR, et al. - Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology, 2002, 59, 669-674.
Sacco RL. - Clinical practice. Extracranial carotid stenosis. N Engl J Med, 2001, 345, 1113-1118.
Chaturvedi S, Fessler R. - Angioplasty and stenting for stroke prevention: good questions that need answers. Neurology, 2002, 59, 664-668.
Benesch CG, Chimowitz, MI. - Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID investigators. Neurology, 2000, 55, 465-466.
Lip GY, Hart RG, Conway DS. - Antithrombotic therapy for atrial fibrillation. BMJ, 2002, 7371, 1022-1025.
Coull BM, Williams LS, Goldstein LB, et al. - Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology, 2002, 59, 13-22.
Coull BM, Williams LS, Goldstein LB, et al. - Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke, 2002, 33, 1934-1942.
McGaw D, Harper R. - Patent foramen ovale and cryptogenic cerebral infarction. Intern Med J, 2001, 31, 42-47.
Mas JL, Arquizan C, Lamy C, et al. - Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med, 2001, 345, 1740-1746.
Schievink WI. - Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med, 2001, 344, 898-906.
Levine JS, Branch DW, Rauch J. - The antiphospholipid syndrome. N Engl J Med, 2002, 346, 752-763.
Khamashta MA, Cuadrado MJ, Mujic F, et al. - The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med, 1995, 332, 993-997.
Jennekens FG, Kater L. - The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford), 2002, 41, 605-618.
Jennekens FG, Kater L. - The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford), 2002, 41, 619-630.
Mangoni AA, Jackson SH. - Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med, 2002, 112, 556-565.